Insider Transactions in Q1 2025 at Biomarin Pharmaceutical Inc (BMRN)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 19
2025
|
Erin Burkhart GVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,295
-7.1%
|
$91,945
$71.52 P/Share
|
|
Mar 17
2025
|
George Eric Davis EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,940
+13.5%
|
-
|
|
Mar 17
2025
|
Erin Burkhart GVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,970
+24.65%
|
-
|
|
Mar 17
2025
|
Cristin Hubbard EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,310
+28.93%
|
-
|
|
Mar 17
2025
|
Charles Greg Guyer EVP, Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,310
+14.14%
|
-
|
|
Mar 17
2025
|
Gregory R Friberg EVP, Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,750
+27.49%
|
-
|
|
Mar 17
2025
|
Alexander Hardy Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,360
+20.17%
|
-
|
|
Mar 17
2025
|
Brian Mueller EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,640
+14.29%
|
-
|
|
Mar 14
2025
|
George Eric Davis EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,249
-18.85%
|
$1,121,181
$69.44 P/Share
|
|
Mar 14
2025
|
Erin Burkhart GVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
823
-6.28%
|
$56,787
$69.44 P/Share
|
|
Mar 14
2025
|
Charles Greg Guyer EVP, Chief Technical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,127
-22.96%
|
$1,388,763
$69.44 P/Share
|
|
Mar 14
2025
|
Alexander Hardy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,933
-2.19%
|
$202,377
$69.44 P/Share
|
|
Mar 14
2025
|
Brian Mueller EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,497
-18.2%
|
$1,276,293
$69.44 P/Share
|
|
Mar 06
2025
|
Charles Greg Guyer EVP, Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
7,034
-7.43%
|
$499,414
$71.28 P/Share
|
|
Feb 28
2025
|
Charles Greg Guyer EVP, Chief Technical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,287
-4.33%
|
$304,377
$71.16 P/Share
|
|
Feb 25
2025
|
Brian Mueller EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,067
+9.9%
|
-
|
|
Feb 25
2025
|
George Eric Davis EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,067
+11.69%
|
-
|
|
Feb 25
2025
|
Charles Greg Guyer EVP, Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,067
+10.17%
|
-
|
|
Feb 24
2025
|
Timothy P Walbert Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,130
+50.0%
|
-
|
|
Feb 24
2025
|
Erin Burkhart GVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,344
-9.3%
|
$91,392
$68.38 P/Share
|